Medication info

Kretamine Injection

Prescription medicationInjectionsInjection
Ingredient · strength
L-Isoleucine›0.56g / 100mLL-Leucine›1.25g / 100mLL-Lysine Acetate›1.24g / 100mLL-Methionine›0.35g / 100mLL-Phenylalanine›0.935g / 100mLL-Threonine›0.65g / 100mLL-Tryptophan›0.13g / 100mLL-Valine›0.45g / 100mLL-Alanine›0.625g / 100mLL-Arginine›0.79g / 100mLL-Glutamic Acid›0.65g / 100mLL-Histidine›0.6g / 100mLL-Proline›0.33g / 100mLL-Aspartic Acid›0.38g / 100mLL-Cysteine›0.1g / 100mLGlycine›1.07g / 100mLL-Serine›0.22g / 100mLL-Tyrosine›35mg / 100mL
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
This medication is a colorless to pale yellow transparent solution contained in a polypropylene aquatic injection vial.
Packaging
500 mL/pack
Approval status
Active

MFDS item code 199300320 · Notified 1993.05.07 · Insurance code 644903962

Summary

Main use
Improvement of nutritional status (hypoproteinemia, before and after surgery, etc.)
Who receives it
Adults · Children
Adult administration
Peripheral intravenous administration: Adults: Slowly infuse 200~400 mL intravenously per dose. Infusion rate: At a rate of 200 mL over 120 minutes (approximately 25 drops per minute), an amino acid amount of around 10 g per hour is desirable for utilization by the body. Infuse slowly in elderly patients and patients with severe illness. Central venous administration: Continuously infuse 400~800 mL per day into a central vein according to the hypercaloric infusion method. For efficient utilization of amino acids by the body, concurrent administration with a sugar-containing infusion is desirable. Adjust the dose and infusion rate appropriately in elderly patients, burn patients with high protein requirements, and similar cases.
Child administration
Peripheral intravenous administration: Children: Infuse slowly. Central venous administration: Children: Adjust the dose and infusion rate appropriately.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Improvement of nutritional status (hypoproteinemia, before and after surgery, etc.)

  • Hypoproteinemia
  • undernutrition
View approved original text

Amino acid supplementation is needed in cases of hypoproteinemia, undernutrition, and conditions such as pre- and post-surgery. In these situations, the body does not receive sufficient protein, so providing amino acids helps promote protein synthesis in the body, improves nutritional status, and aids recovery. Therefore, amino acid supplementation is used for hypoproteinemia, undernutrition, and pre- and post-operative states.

How it is given

Adult administration

Peripheral intravenous administration: Adults: Slowly infuse 200~400 mL intravenously per dose. Infusion rate: At a rate of 200 mL over 120 minutes (approximately 25 drops per minute), an amino acid amount of around 10 g per hour is desirable for utilization by the body. Infuse slowly in elderly patients and patients with severe illness. Central venous administration: Continuously infuse 400~800 mL per day into a central vein according to the hypercaloric infusion method. For efficient utilization of amino acids by the body, concurrent administration with a sugar-containing infusion is desirable. Adjust the dose and infusion rate appropriately in elderly patients, burn patients with high protein requirements, and similar cases.

Child administration

Peripheral intravenous administration: Children: Infuse slowly. Central venous administration: Children: Adjust the dose and infusion rate appropriately.

Precautions

This medication must be used strictly under the direction of a physician and should not be taken or discontinued arbitrarily. Patients with hepatic coma or at risk of hepatic coma, severely impaired kidney function, or high blood nitrogen levels should not use this medication. Moreover, patients with metabolic disorders, severe heart failure, pulmonary edema, very low or absent urine output, high sodium or chloride levels, or a history of myocardial infarction should also not receive this medication. This medication should be used carefully in patients with severe acidosis, congestive heart failure, swelling due to sodium retention, hyperkalemia, or liver or kidney dysfunction. This medication contains sodium bisulfite, which can provoke allergic reactions or asthma attacks in sensitive individuals, especially those with asthma. During administration, side effects such as rash, nausea, vomiting, chest discomfort, palpitations, and increased blood pressure may occur, and rarely severe reactions such as difficulty in breathing or shock may occur. Administering in large amounts quickly may result in acidosis, so care should be taken with the rate of administration. When using this medication in large quantities or concurrently with electrolyte-containing solutions, careful monitoring of electrolyte balance in the body is essential. Diabetic patients should frequently check their blood sugar levels to respond to changes in glucose levels. When used with tetracycline antibiotics, the protein-sparing effect of this medication may decrease, so caution is required when co-administering. The safety of this medication during pregnancy has not been established, thus it should only be used when the therapeutic benefit outweighs the risks. In children, kidney function may be immature, so concentrations should be kept low and serum ammonia levels should be monitored frequently to reduce the risk of hyperammonemia. Elderly patients may have declined physical function, and thus care should be taken to adjust the rate of administration and dosage accordingly. This medication contains electrolytes which may cause electrolyte imbalances when administered in large amounts, so caution is necessary, and the infusion rate should be slow. Before use, verify that the solution is clear and without abnormalities, prepare it in an aseptic state, and ensure sterilization of injection equipment.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • tachycardia
  • hypertension
  • acidosis
  • chills
  • fever
Show 25 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary spasm
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. Avoid direct sunlight and store in a place at normal room temperature, neither too hot nor too cold.

Appearance and packaging

Appearance

This medication is a colorless to pale yellow transparent solution contained in a polypropylene aquatic injection vial.

Package unit

500 mL/pack

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.